Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

PURPOSE: The purpose of this study was to compare the outcome of patients with intermediate-risk rhabdomyosarcoma (RMS) treated with standard VAC (vincristine, dactinomycin, and cyclophosphamide) chemotherapy to that of patients treated with VAC alternating with vincristine, topotecan, and cyclophos...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Arndt, Carola A.S., Stoner, Julie A., Hawkins, Douglas S., Rodeberg, David A., Hayes-Jordan, Andrea A., Paidas, Charles N., Parham, David M., Teot, Lisa A., Wharam, Moody D., Breneman, John C., Donaldson, Sarah S., Anderson, James R., Meyer, William H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2009
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2773476/
https://ncbi.nlm.nih.gov/pubmed/19770373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.3768
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky